Drug

Amivantamab clinical trials

Also written JNJ-61186372 and RYBREVANT.

studies test it: 33
open now: 12
in phase 3: 7
first study started: 2018

Keep track of what changes. Save the amivantamab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

33 studies that test it; most in 2023 (7)

Studies that test amivantamab, by start year
Year	Studies
2018	1
2019	1
2020	2
2021	4
2022	5
2023	7
2024	7
2025	3
2026	3

By phase

A phase 1/2 study counts in both.

Phase 1: 9
Phase 2: 24
Phase 3: 7

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Non-Small-Cell Lung: 19
Colorectal Neoplasms: 5
Glioblastoma: 1
Salivary Gland Neoplasms: 1
Squamous Cell Carcinoma of Head and Neck: 1
Carcinoma, Hepatocellular: 1
Stomach Neoplasms: 1

Who runs them

Industry 18 · Other 15

Janssen Research & Development, LLC (16) · Memorial Sloan Kettering Cancer Center (2) · Latin American Cooperative Oncology Group (2) · Yonsei University (2) · University of Colorado, Denver (1) · M.D. Anderson Cancer Center (1) · AstraZeneca (1) · Institute of Cancer Research, United Kingdom (1)

Often tested with

Tested in the same studies.

Lazertinib (6) · Dexamethasone (1) · Montelukast (1) · Methotrexate (1) · Capmatinib (1) · Cetrelimab (1) · Tepotinib (1) · Osimertinib (1)

Studies

Open first, then newest update. How each study uses amivantamab is read from its arms, and is right about nine times in ten.

Testing it · 33

See all 33 studies that test amivantamab →

Given in every arm · 9 — amivantamab is usual care beside what is tested

Codes

What other systems call amivantamab · ClinicalTrials.gg INT001661

MeSH (NLM) C000718215amivantamabConfirmed ClinicalTrials.gov, NLM
UNII (FDA) 0JSR7Z0NB6AMIVANTAMABConfirmed FDA, NLM, Wikidata
RxNorm 2549199One source FDA
Wikidata Q106957199amivantamabConfirmed FDA, NLM, Wikidata
NCI Thesaurus C124993AmivantamabOne source FDA
DrugBank DB16695One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	C000718215	amivantamab	Confirmed ClinicalTrials.gov, NLM
UNII (FDA)	0JSR7Z0NB6	AMIVANTAMAB	Confirmed FDA, NLM, Wikidata
RxNorm	2549199	—	One source FDA
Wikidata	Q106957199	amivantamab	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C124993	Amivantamab	One source FDA
DrugBank	DB16695	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Amivantamab clinical trials

How studies write it

Name

Brand

Development codes

Other names

Combined with it in one product